Brought to you by 
Centocor works on immunotherapeutic under MRC patent license
27 Feb 2009
Executive Summary
Medical Research Council Technology, the tech transfer arm of Medical Research Council (MRC), has licensed J&J's Centocor Ortho Biotech exclusive rights to its immunotherapeutic for respiratory disease and related patents.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Centocor works on immunotherapeutic under MRC patent license
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice